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Abstract
Background: Infertility affects about 15% of couples worldwide, and the male factor
alone is responsible for approximately 50% of the cases. Genetic factors have been
found to play important roles in the etiology of azoospermia and severe oligospermia
conditions that affect 30% of individuals seeking treatment at infertility clinics.
Objective: To determine the frequency of chromosomal abnormalities and Y
chromosome microdeletion in infertile men.
Materials and Methods: A total of 100 infertile men with abnormal semen parameters
were included in this study from 2014 to 2018. Chromosomal analysis was carried out
using standard G-banding using Trypsin Giemsa protocol. Multiplex polymerase chain
reaction was used to determine the Y microdeletion frequency.
Results: All participants were aged between 22 and 48 yr with a mean and
standard deviation of 35.5 ± 5.1. Of the 100 subjects included in the study,
three had Klinefelter syndrome-47,XXY, one had balanced carrier translocation-
46,XY,t(2;7)(q21;p12), one with the balanced carrier translocation with inversion
of Y chromosome 45,XY,der(13;14)(q10;q10),inv(Y), one had polymorphic variant of
chromosome 15, one had Yqh-, and another had an inversion of chromosome 9. Y
chromosome microdeletion of Azoospermia factor c region was observed in 2% of the
cases. To the best of our knowledge, the current study is the first reported case with
unique, balanced carrier translocation of chromosome 2q21 and 7p21.
Conclusion: The present study emphasizes the importance of routine cytogenetic
screening and Ymicrodeletion assessment for infertile men, which can provide specific
and better treatment options before undergoing assisted reproductive technology
during genetic counseling.
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1. Introduction
Infertility is a disease of the reproductive
system and the incapability of a couple at
reproductive age to conceive naturally after 12
months or more of regular unprotected sexual
intercourse (1). Infertility affects about 15% of
couples worldwide, and men are accountable for
around 50% of the cases. The leading causes of
infertility in men are abnormal semen parameters




Spermatogenesis is a complex process
involving nearly 2,300 genes in the formation
and regulation of spermatozoa (3). Based on
systematic cytogenetic studies carried out on
male infertility, it is estimated that the incidence
of chromosomal aberrations is about 5.8% (4).
Chromosomal abnormalities can be numerical
(gain or loss of a chromosome) or structural
(balanced or unbalanced chromosome) and
involve both sex chromosomes and autosomes.
Y chromosome structural abnormalities like
deletion, ring chromosome, and isochromosome
may lead to different phenotypes. Deletion
of the sex-determining region located in the
p arm of the Y chromosome directly disturbs
the testis differentiation, which leads to
phenotypically female with streak gonads, while
the Y microdeletions especially involved with
azoospermia factor (AZF) a, b, and c regions on
the q arm of the Y chromosome lead to male
infertility (5). The incidence of deletions on the
Y chromosome was estimated to be 7-8% with a
higher deviation (6).
Severe oligozoospermia and azoospermia with
normal karyotype have been reported in 10-15% of
the infertile males, involving deletion of the deleted
in azoospermia gene of the AZFc region (7).
Homologous recombination amongst Y-
specific repeats generates deletions, which
leads to spermatogenic failure due to the
removal of AZF functional genes (8). The Y
microdeletion frequency fluctuates from 0.9-
55.5% in various studies conducted on infertile
male. The recommended sequence-tagged sites
(STS) markers by the European Academy of
Andrology (EAA) are the only six to find out
Y microdeletion in infertile male with a higher
detection rate of almost 90% (9). However, the
recommendation of Y microdeletion to infertile
men for their routine clinical practice has not been
adopted regularly.
This study has been conducted to determine
the frequency of chromosomal abnormalities and
develop a molecular-level diagnosis of male
infertility and to standardize the Y microdeletion
protocol.
2. Materials and Methods
This cross-sectional descriptive study was
performed on 100 infertile men with abnormal
semen parameters such as azoospermia,
oligozoospermia, teratozoospermia, and
asthenozoospermia, referred to the KSHEMA
Centre for Genetic Services (K. S. Hegde
Medical Academy, Mangalore, India) between
2014 and 2018. The studied participants were
aged between 22 and 48 yr with a mean
and standard deviation of 35.5 ± 5.1 yr.
Infertile men with azoospermia, oligospermia,
teratospermia and asthenozoospermia were
included in this study. Patients who were
not willing to participate and having normal
sperm count were excluded. Peripheral blood
(2 ml) was collected from all participants in
heparin and EDTA vacutainer for chromosomal
analysis and Y microdeletion detection,
respectively.
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2.1. Chromosomal analysis
Chromosomal analysis was carried out by
the standard G-banding protocol (10) with
minor modifications. The culture was set
up in a 15-ml centrifuge tube with 500-µl
whole blood and 5 ml PB - Peripheral blood
max media (Gibco USA). Phytohemagglutinin
(Phytohemagglutinin Form M: Gibco USA), 300
µl was added to the culture as a mitogen and
incubated at 37°C in 5% CO2 (Panasonic) for 68
hr.
Colcemid (0.08 µg/ml) (Gibco, USA) 45 µl was
added to arrest the cells at the metaphase stage
at the 68th hr.
Next, 9 ml of 0.075 M KCl (Merck, India) was
added and incubated at 37°C for 13 min. Then,
the cells were fixed by using a 3:1 ratio of
methanol (LOBA Chemie, India) and acetic acid
(Merck, India) (Carnoy’s fixative). The cell pellet
was dropped on slides and aged overnight at
60°C hot air oven (Ascension Innovation) overnight.
G-banding using Trypsin Giemsa was done by
treating with 0.05% trypsin and staining with 4%
Giemsa stain.
Twenty well-spread metaphases with excellent
band resolution were selected for analysis under
oil immersion (100×) using a bright fieldmicroscope
(BX53, Olympus, Japan).
Karyotypes were reported using the GENASIS
Software (Version 7.2, Applied Spectral Imaging,
Israel). Identified chromosomal abnormalities were
designated as per the International System for
HumanCytogenetic Nomenclature 2013 guidelines
(11).
2.2. Y Microdeletion
Genomic DNA was extracted by a phenol-
chloroform manual method from peripheral blood
leukocytes. A series of 10 STS markers were
analyzed by multiplex polymerase chain reaction
(PCR) using commercially available primers
(Invitrogen in Life technologies). The STS markers
used in this study for AZFa are sY84, sY86; for
AZFb sY127, sY134, and sY143; for AZFc sY156,
sY158, sY254, and sY255.
Microdeletions on AZFa, AZFb, and AZFc were
carried out using the multiplex PCR technique. The
Ymicrodeletion of genomic DNAwas standardized
based on Simoni et al guidelines withmodifications
(12).
Also, an additional primer was used to amplify
the ZFY regions as internal controls. Table I shows
the primer sequences used and the size of related
PCR products.
Along with each set of primers as an internal
control, we ran one female DNA sample, one
normal male DNA, and water as a substitute of
DNA every time. The genomic DNA (100 ng/μl)
was added to a mixture of 50 mM MgCl2, 100
mM each dNTP, 100 μmol of primer pairs, and
1 unit of Taq DNA polymerase (Invitrogen, Life
technologies, USA), adjusted to a final volume
of 25 μl. PCR program was carried out on a
Bio-Rad Thermocycler (USA). Initial denaturation
was carried out at 95°C for 10 min, followed
by 35 cycles of 94°C for 30 sec denaturation
and annealing at 58°C for 90 sec with 1-min
extension at 72°C. For Multiplex B, C1 and C2,
94°C for 5 min as initial denaturation, continued
with 35 cycles of 94°C for 30 sec, annealing
at 58°C for 30 sec, and extension at 72°C for
30 sec was carried out. All PCR amplification
products were subjected to agarose (2%) gel
electrophoresis of 100 V current by using 1X Tris
base, acetic acid, and EDTA buffer, with Ethidium
bromide along with 100 bp DNA ladder and
visualized under ultraviolet light using the Geldoc
(BIORAD - GelDoc EZ Imager, USA). If any deleted
specific STS primer bands were noticed, then it
was considered that the associated region was
deleted.
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Table I. List of STS markers and primer sequences used for detection of Y chromosome microdeletion
STS Region Primer sequence Product size (bp)
sY84 AZFa 5’AGA AGG GTC TGA AAG CAG GT3’5’GCC TAC TAC CTG GAG GCT TC3’ 326
sY86 AZFa 5’GTG ACA CAC AGA CTA TGC TTC3’5’ACA CAC AGA GGG ACA ACC CT3’ 320
sY127 AZFb 5’GGC TCA CAA ACG AAA AGA AA3’5’CTG CAG GCA GTA ATA AGG GA3’ 274
sY134 AZFb 5’GTC TGC CTC ACC ATA AAA CG3’5’ACC ACT GCC AAA ACT TTC AA3’ 301
sY143 AZFb 5’GCA GGA TGA GAA GCA GGT AG3’5’CCG TGT GCT GGA GAC TAA TC3’ 311
sY156 AZFc 5’AGG AAC TGG CAG GAT TAG CC3’5’ATG TCA GGG TTT CCT TTG CC3’ 950
sY158 AZFc 5’CTC AGA AGT CCT CCT AAT AGT TCC3’5’ACA GTG GTT TGT AGC GGG TA3’ 231
sY254 AZFc 5’GGG TGT TAC CAG AAG GCA AA3’5’GAA CCG TAT CTA CCA AAG CAG C3’ 400
sY255 AZFc 5’GTT ACA GGA TTC GGC GTG AT3’5’CTC GTC ATG TGC AGC CAC3’ 126
Internal Positive ZFY Yp11.3 5’ACC RCT GTA CTG ACT GTG ATT3’5’GCA CYT CTT TGG TAT CYG AGA3’ 495
All primers were non-polymorphic short DNA fragments, and we designed them into four sets as multiplex A, B, C1, and C2.
Multiplex A: 4 Primers - ZFY, sY86, sY127, sY254, Multiplex B: 4 Primers - ZFY, sY84, sY134, sY255, Multiplex C1: 2 Primers -
sY143, sY158, Multiplex C2: 1 Primer - sY156
2.3. Ethical considerations
The ethical clearance for this study was obtained
from the institutional ethics committee (Ref. No.
NU/CEC/Ph.D-19/2014), and informed consent
was obtained from all participants before the
study.
2.4. Statistical analysis
The collected information was summarized
using frequency/percentage for qualitative
data and mean with standard deviation for
quantitative data. The frequency was used
to determine the chromosomal analysis and
Y microdeletion. Data management and
analysis were performed using Microsoft
Excel and Statistical Package for the Social
Sciences, version 16.0.1 (SPSS Inc., Chicago, IL,
USA).
3. Results
Of the 100 participants, 68% were infertile
men with azoospermia, 18% with oligospermia,
6% with severe oligospermia, and 8% with
oligoasthenoteratozoospermia. All of them
had chromosomal analysis, of which 37
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cases were reported earlier (13), and in the
remaining 63 are described in the present
study.
3.1. Determination of chromosomal
abnormalities frequency
Of the 63 cases described in the current study,
normal karyotype of 46,XY was observed in 53
cases, chromosomal abnormalities of 47,XXY-
Klinefelter syndrome in 3 cases, balanced carrier
translocation of 46,XY,t(2;7)(q21;p12) (Figure
1) in 1 infertile man with severe oligospermia,
45,XY,der(13;14)(q10;q10),inv(Y) (Figure 2) in
another case with oligospermia, polymorphic
variants of chromosome Y- inv(Y) in 2 cases,
inversion of chromosome 9 in 2 cases, and 15ps+
in one case (Table II).
3.2. Determination of Y-microdeletion
frequency
Using 10 STS markers in 100 infertile men
detected only two infertile males (2%) with deletion
of AZFc region on Yq11. Y microdeletion detection
was negative in 98% of the cases. The tested
four specific STS markers sY156, sY158, sY254,
sY255 for AZFc region on the Y chromosome was
absent in one azoospermic male and one severe
oligospermic male.
Table II. Chromosomal abnormalities observed in infertile men
Karyotype Cases [n (%)]
No chromosomal abnormalities 46,XY 53 (84)




Polymorphic variant of chromosome 15 46,XY,15ps+ 1 (1.6)
Polymorphic variant of chromosome Y 46,XY,qh- 2 (3.2)
Inversion of chromosome 9 46,XY,inv(9)(p11q13) 2 (3.2)
Figure 1. Karyotype with balanced translocation of chromosomes 2 and 7 - 46,XY,t(2;7)(q21;p21).
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like balanced carrier translocations and Y
microdeletions on the AZF region are the reason
for the many infertile males, but not always
practiced routinely. Failure to screen genetic
factors such as karyotyping and Y microdeletion
leads to unsuccessful assisted reproductive
technology (ART) procedure, and there will
be a chance to transfer the same abnormality
to the offspring. Specifically, balanced carrier
translocations cause the production of unbalanced
spermatozoa and offspring with mental retardation,
whereas Y microdeletion leads to offspring with
the same problem of infertility, especially when the
offspring is male.
The last 20 yr of research has indicated that
various chromosomal abnormalities caused
by the interruption of spermatogenesis in
different stages end up with infertility. Former
studies have shown a high prevalence of
chromosomal abnormalities eventually in
infertile azoospermic men with sex chromosome
abnormalities than oligozoospermic patients with
frequent autosomal abnormalities (14). In the
present study, we observed sex chromosomal
abnormalities and autosomal abnormalities
in azoospermic men and reported only one
oligozoospermic male with balanced carrier
translocation.
Chromosomal analysis is important in identifying
the cause of Klinefelter’s syndrome with the
phenotypic features of tall stature, testicular
atrophy, azoospermia, and infertility with a
prevalence of 0.1% in the general population (15). In
the present study, we observed three azoospermic
men with Klinefelter syndrome - 47,XXY. The
extra X chromosome of Klinefelter syndrome
influences the mechanism of spermatogenesis,
which affects testicular development, Leydig
cell insufficiency, Sertoli, and Leydig cells
apoptosis regulation (16). Non-disjunction of
sex chromosomes is the primary genetic cause
for the Klinefelter syndrome, which leads to
the presence of extra X chromosomes. The
occurrence of the additional X chromosome
by maternal during oogenesis is likely to occur
from nondisjunction in meiosis I or II while in
paternal (spermatogenesis) can only be derived
from nondisjunction in meiosis I (17). Klinefelter
syndrome is always diagnosed when a person
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undergoes fertility assessment not at their earlier
age.
Balanced reciprocal translocation carriers have a
higher risk of producing unusual pregnancies with
unbalanced chromosomal aberrations by precise
functional roles of genes at particular breakpoints
in spermatogenesis (18). A detailed molecular
analysis of the translocated region is needed
because of the possible cause of this region’s
involvement in male infertility due to disruption of
meiosis (19). Infertility cases with various balanced
translocations of different chromosomes such
as t(1;19), t(3;13), t(1;9), t(9;10), t(9;3), t(1;4), t(7;8),
t(3;6), t(1;11), t(1;10), t(3;18), t(7;9); t(7;14), t(7;17),
(13;19), t(6;17) have been reported earlier (20, 21).
According to the existing studies, 7q31 and 7q36
breakpoints are related to pre-gestational infertility,
whereas 7q21.2, 7q22, and 7q32 breakpoints are
associated with gestational infertility (22). However,
whichever category of infertility is involved with
chromosome 7 must be counseled based on
specific breakpoints.
Further, balanced carrier translocation of
2p1;7q32, 2p13;7q34, 2q31;7q34, 2p23;7p22
have also been reported earlier (23). Based
on our knowledge, 2q21;7p21 was observed
for the first time in the present study. Infertile
men with carriers of der(13;14) frequency were
approximately 10-fold higher than a newborn
survey with missed abortions, stillbirths, and
offspring with a congenital malformation (24).
While most of the Robertsonian translocations are
inherited from paternal, nearly 40% can be de novo
translocations due to rearrangements in meiosis
(25). However, in our study, we observed a de
novo translocation of 45,der(13;14) with inversion Y
in one azoospermic male, which is not a frequent
case ever reported earlier.
Most infertility cases with inversion Y have
not influenced any of the phenotypic features,
however, a del(Y)(q11.1-q11.2) or disruption of
the deleted in azoospermia genes caused by
pericentric inversion has been reported in one
male infertility case (20). The 46,XY,qh- karyotype
is considered as a normal polymorphic variant,
which occurs in the general population. A study
conducted by Pan et al (26) with 46,XY,qh-
cases perceived 64.7% of patients with AZF
microdeletion and insisted that Y microdeletion
screening is a must in such type of cases. In
the present study, we have observed 2% of the
patients with 46,XY,qh- and their Y microdeletion
results were normal. Inversions occur when a
single chromosome undergoes two breaks and
is reconstructed with the segment between
the breaks inverted during meiosis, which
can be either pericentric or paracentric. The
heterochromatin polymorphisms of autosomes
(chromosomes 1, 9, 16 and Y) reported by earlier
studies revealed no phenotypic or clinically
adverse effects or any apparent association with
infertility (27).
A study conducted in Korea with 1,226
infertile males showed the overall frequency
of Y chromosome microdeletions in 10.93%
(134/1,226) patients, of which the AZFc region
was the most frequent with 51.49% (69/134),
followed by the AZFb with 8.21% and AZFa
with 7.46% (28). A study conducted in Japan
with 162 infertile males showed seven (4.3%)
cases were positive for Y microdeletion (29).
Two other studies conducted in Egypt showed
4 out of 100 infertile men (4%) (30), and 0/40
infertile males (0%) (31) had absence of AZFc
region on the Y chromosome. Furthermore, a
study performing Y-chromosome screenings on
1,387 infertile men in Portugal reported that AZF
microdeletions in 128 cases: 17 (1.2%) in AZFa,
26 (1.9%) in AZFb, and 85 (6.1%) in AZFc (32). A
study conducted on 1,636 infertile subjects in
Mumbai showed 3.4% (56/1,636) of the cases had
Yq microdeletions (6). Various Indian studies listed
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in Table III with different STS markers used for Y
microdeletion showed different frequency of Y
microdeletion.
Variation among Y microdeletion frequency was
due to the selection of STS markers, inclusion
and exclusion criteria of studied participants, and
predominantly their ethnicity. In the present study,
only 2% of Y microdeletion was detected, which
indicates that the southern-region population had
a lower Y microdeletion frequency. Along with
EAA-recommended STS markers, each ethnicity
population has to standardize with additional
markers to increase the Y microdeletion detection
rate (9). A study conducted by Rani and colleague
(33) illustrated a high frequency of deletion (29.4%)
in the AZF region and concluded that ethnicity
plays a significant role in Indian populations.
Chromosomal abnormalities and Y microdeletion
have emerged as a leading cause of male infertility.
The strength of our dataset is the reliability of the
results due to homogeneous procedures carried
out.

















Thangaraj et al. (34) Kolkata 340 29 (8.5) 32 6 6.5
Swarna et al. (35) Hyderabad 50 4 (8.0) 2 1 2
Athalye et al. (36) Mumbai 100 12 (12.0) 18 2 6
Rao et al. (37) Hyderabad 251 10 (3.9) 17 5 1.5
Kumar et al. (38) New Delhi 109 7 (8.5) 8 6 8.5
Sachdeva et al. (9) New Delhi 200 21 (10.5) 25 6 3
Mahanta et al. (39) Assam 100 5 (5) 4 6 3
Ambulkar et al. (40) Wardha 58 6 (10.7) 10 6 10.7
Sathyanarayana et al. (41) Mysore 200 1 (0.50) 6 2 0
Rani et al. (33) Hyderabad 973 286 (29.4) 35 6 16.4
Present study (2019) Mangalore DK 100 2 (2) 10 6 2
DK: Dakshina kannada, EAA: European academy of andrology, STS: Sequence-tagged sites
5. Conclusion
The present study emphasizes the importance of
routine cytogenetic screening of all infertile males
before undergoing ART. It is not only to identify
the underlying cause of infertility but also to
minimize the risk of transmission of chromosomal
abnormalities. Infertile males with abnormal
semen parameters should undergo screening of
Y microdeletion before the treatment to reducing
the transmission of the same abnormality to
the offspring. When the male partner has an
abnormal autosomal karyotype abnormality,
genetic counseling should be offered to the
couple seeking fertility treatment. The observed
results would give a better understanding of
the etiology and particular phenotype of male
infertility. To the best of our knowledge, this
study reports for the first time a case with unique,
balanced carrier translocation of chromosome
2q21 and 7p21. Cytogenetic and Y microdeletion
screening would provide specific and better
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treatment options during genetic counseling of
infertile male.
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